Deciphera Pharmaceuticals Cash from Financing (TTM) Trends

Deciphera Pharmaceuticals Inc (DCPH)

25.46 +0.02 (+0.06%) USD | NASDAQ | May 17, 16:00

25.46 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	17.84M
December 31, 2023	152.00M
September 30, 2023	151.59M
June 30, 2023	136.21M
March 31, 2023	299.60M
December 31, 2022	164.99M
September 30, 2022	166.49M
June 30, 2022	167.99M
March 31, 2022	5.449M
December 31, 2021	14.89M
September 30, 2021	40.70M
June 30, 2021	42.23M
March 31, 2021	44.93M

Date	Value
December 31, 2020	226.80M
September 30, 2020	199.77M
June 30, 2020	631.02M
March 31, 2020	626.65M
December 31, 2019	436.37M
September 30, 2019	435.67M
June 30, 2019	0.693M
March 31, 2019	187.14M
December 31, 2018	185.99M
September 30, 2018	313.42M
June 30, 2018	311.14M
March 31, 2018	176.42M
December 31, 2017	176.40M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.693M

Minimum

Jun 2019

631.02M

Maximum

Jun 2020

198.10M

Average

158.50M

Median

Cash from Financing (TTM) Benchmarks